BIOIVT
The field of advanced therapeutics, including cell and gene therapy, continues to hold remarkable promise for the treatment of cancer and other chronic conditions. BioIVT’s immune cell portfolio includes everything you need to develop advanced therapies. From industry-standard leukapheresis products to timesaving, ready-to-use isolated immune cell subsets, we provide the cells you need, when you need them. Through our 425 worldwide collections sites and 11 donor centers, we have an extensive network of healthy, recallable donors and truly representative starting material from oncology, autoimmune and infectious disease-state.
